Accueil › 🇺🇸 États-Unis › Santé TinyGemsBreaks – Helus Pharma (TM) (NASDAQ: HELP) (Cboe CA: HELP) Advances HLP003 Phase 3 Program, Targets Q4 2026 Topline Data 📅 14/08/2026 13:15 📰 financialcontent 👁️ 3 lectures 🌍 États-Unis 📂 Santé This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.